Zydus Lifesciences informs about press release

17 May 2024 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated May 17, 2024 titled ‘Zydus and MSN announces exclusive licensing and supply agreement for Cabozantinib Tablets (generic version of CABOMETYX®) for the US market’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

1001.15 -22.45 (-2.19%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.